Invention Grant
- Patent Title: Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
-
Application No.: US16197902Application Date: 2018-11-21
-
Publication No.: US10761091B2Publication Date: 2020-09-01
- Inventor: Kay-Gunnar Stubenrauch , Rudolf Vogel
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche, Inc.
- Current Assignee: Hoffmann-La Roche, Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Foley & Lardner LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4dda2d24
- Main IPC: A61K39/395
- IPC: A61K39/395 ; G01N33/53 ; G01N33/543 ; C07K16/28 ; G01N33/68

Abstract:
Herein is reported an enzyme linked immunosorbent assay for the detection of anti-drug antibodies against a drug antibody in a sample comprising a capture drug antibody and a tracer drug antibody, wherein the capture drug antibody and the tracer drug antibody are employed in a concentration of 0.5 μg/ml or more, the sample is incubated simultaneously with the capture drug antibody and the tracer drug antibody for 1 to 24 hours, the capture drug antibody and the tracer drug antibody are derivatized via a single lysine residue, the sample comprises 10% serum, and oligomeric human IgG is added to the sample prior to the incubation with the capture drug antibody and the tracer drug antibody.
Public/Granted literature
- US20190094216A1 INTERFERENCE-SUPPRESSED IMMUNOASSAY TO DETECT ANTI-DRUG ANTIBODIES IN SERUM SAMPLES Public/Granted day:2019-03-28
Information query